The European biotech sector is at a turning point, with the upcoming EU Biotech Act set to drive innovation and competitiveness. While Europe excels in research, it struggles to scale biotech breakthroughs into globally competitive companies. Successful ecosystems like those in the Netherlands and Massachusetts highlight the power of integrating innovation with industry, academia, and investment. To build a thriving biotech landscape, Europe must foster collaboration among policymakers, investors, and industry leaders. In this session, a high-level panel will discuss public-private partnerships, biotech financing, and regulatory challenges, with international experts sharing lessons from the Dutch, Belgium, US and Swedish biotech hubs.